Cargando…

Effects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidence

OBJECTIVE: Treatment of menopausal symptoms by compounds with tissue-selective estrogen agonist/antagonist effects, often called selective estrogen receptor modulators, has been researched as an alternative to the use of estrogen therapy. These structurally diverse molecules elicit tissue-dependent...

Descripción completa

Detalles Bibliográficos
Autores principales:	Archer, David F., Carr, Bruce R., Pinkerton, JoAnn V., Taylor, Hugh S., Constantine, Ginger D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott-Raven Publishers 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481022/ https://www.ncbi.nlm.nih.gov/pubmed/25423325 http://dx.doi.org/10.1097/GME.0000000000000365

Ejemplares similares

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program
por: Constantine, Ginger D., et al.
Publicado: (2015)

Overall Safety of Ospemifene in Postmenopausal Women from Placebo-Controlled Phase 2 and 3 Trials
por: Simon, James A., et al.
Publicado: (2018)

Compounded non-FDA–approved menopausal hormone therapy prescriptions have increased: results of a pharmacy survey
por: Pinkerton, JoAnn V., et al.
Publicado: (2016)

Experience with ospemifene in patients with vulvar and vaginal atrophy and urinary incontinence: case studies
por: Blanco, Zuramis Estrada, et al.
Publicado: (2020)

Ospemifene for vulvar and vaginal atrophy: an overview
por: Palacios, Santiago
Publicado: (2020)

Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial
por: Constantine, G., et al.
Publicado: (2015)

The female urinary microbiota in relation to the reproductive tract microbiota
por: Chen, Chen, et al.
Publicado: (2020)

Ospemifene: A Novel Option for the Treatment of Vulvovaginal Atrophy
por: Shin, Jae Jun, et al.
Publicado: (2017)

Ospemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data
por: Archer, David F., et al.
Publicado: (2017)

The clinical relevance of the effect of ospemifene on symptoms of vulvar and vaginal atrophy
por: Nappi, R. E., et al.
Publicado: (2015)

Effect of ospemifene on moderate or severe symptoms of vulvar and vaginal atrophy
por: Bruyniks, N., et al.
Publicado: (2016)

Translation and Validation of Bristol Female Lower Urinary Tract Symptoms Questionnaire for Urinary Incontinence in Urdu
por: Bashir, Ahmad, et al.
Publicado: (2022)

Ospemifene May Not Treat Vulvar Atrophy: A Report of Two Cases
por: Goldstein, Andrew T., et al.
Publicado: (2016)

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy
por: Goldstein, S. R., et al.
Publicado: (2014)

Clinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophy
por: Palacios, Santiago, et al.
Publicado: (2016)

Experience with ospemifene in patients with vulvovaginal atrophy treated with laser therapy: case studies
por: Salcedo, Félix Lugo, et al.
Publicado: (2020)

Experience with ospemifene in a patient with vulvovaginal atrophy and dyslipidemia: a case study
por: Rodríguez, Silvia Pilar González
Publicado: (2020)

Adipokines and the Female Reproductive Tract
por: Reverchon, Maxime, et al.
Publicado: (2014)

Organoids of the female reproductive tract
por: Chumduri, Cindrilla, et al.
Publicado: (2021)

Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast
por: Soe, Lin H, et al.
Publicado: (2013)

Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopause
por: Wurz, Gregory T, et al.
Publicado: (2014)

Experience with ospemifene in patients with vulvar and vaginal atrophy and associated sexual dysfunction: case studies
por: López, Ana Rosa Jurado, et al.
Publicado: (2020)

Experience with ospemifene in patients with vulvar and vaginal atrophy: case studies with bone marker profiles
por: del Carmen Pingarrón Santofimia, María, et al.
Publicado: (2020)

Ospemifene in the Management of Vulvar and Vaginal Atrophy: Focus on the Assessment of Patient Acceptability and Ease of Use
por: Cagnacci, Angelo, et al.
Publicado: (2020)

Risk of venous thromboembolism among women receiving ospemifene: a comparative observational study
por: Nordstrom, Beth L., et al.
Publicado: (2022)

Leptotrichia amnionii and the Female Reproductive Tract
por: Gundi, Vijay A.K.B., et al.
Publicado: (2004)

Immune Cells in the Female Reproductive Tract
por: Lee, Sung Ki, et al.
Publicado: (2015)

The metagenome of the female upper reproductive tract
por: Li, Fei, et al.
Publicado: (2018)

Female reproductive tract-organ axes
por: Takada, Kazuhide, et al.
Publicado: (2023)

Anatomy of the Female Koala Reproductive Tract
por: Pagliarani, Sara, et al.
Publicado: (2023)

Effects of Ospemifene on Drug Metabolism Mediated by Cytochrome P450 Enzymes in Humans in Vitro and in Vivo
por: Turpeinen, Miia, et al.
Publicado: (2013)

Experience with ospemifene in patients with vulvar and vaginal atrophy and a history of breast cancer: case studies
por: Lilue, Mariella, et al.
Publicado: (2020)

Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women
por: Pinkerton, JoAnn V., et al.
Publicado: (2015)

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial
por: Archer, David F., et al.
Publicado: (2019)

Bacillus Coli Infections of the Female Urinary Tract
por: Smythe, H. J. Drew
Publicado: (1933)

Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy
por: Pinkerton, JoAnn V., et al.
Publicado: (2016)

Urinary Tract Infection Frequency and Prescription Prophylaxis in Females and Males with Recurrent Urinary Tract Infection
por: Goedken, Amber M., et al.
Publicado: (2023)

Impact of Ospemifene on Quality of Life and Sexual Function in Young Survivors of Cervical Cancer: A Prospective Study
por: De Rosa, Nicoletta, et al.
Publicado: (2017)

Effects of ospemifene on genitourinary health assessed by prospective vulvar-vestibular photography and vaginal/vulvar health indices
por: Goldstein, Irwin, et al.
Publicado: (2019)

Ospemifene displays broad-spectrum synergistic interactions with itraconazole through potent interference with fungal efflux activities
por: Eldesouky, Hassan E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5pkg8tnbikckms7g2481mvibnu